Core Viewpoint - The stock of Meihao Medical (301363) has shown a slight decline, with recent trading data indicating mixed capital flows and performance metrics compared to industry averages [1][2][3]. Group 1: Stock Performance - As of October 16, 2025, Meihao Medical's stock closed at 23.13 yuan, down 0.04%, with a trading volume of 57,800 hands and a total transaction amount of 134 million yuan [1]. - The net inflow of main funds on October 16 was 13.05 million yuan, accounting for 9.72% of the total transaction amount, while retail investors experienced a net outflow of 10.73 million yuan, representing 8.00% of the total [1][2]. Group 2: Financial Metrics - Meihao Medical's total market value is 13.158 billion yuan, with a net asset of 3.595 billion yuan and a net profit of 114 million yuan [3]. - The company's revenue for the first half of 2025 was 733 million yuan, a year-on-year increase of 3.73%, while the net profit decreased by 32.44% to 114 million yuan [3]. - The gross profit margin stands at 37.52%, which is significantly lower than the industry average of 51.85% [3]. Group 3: Industry Comparison - In terms of valuation, Meihao Medical has a price-to-earnings ratio of 57.56, which is lower than the industry average of 66.63, and a price-to-book ratio of 3.66, compared to the industry average of 3.81 [3]. - The company ranks 25th in total market value and 42nd in net assets within the medical device industry [3]. Group 4: Analyst Ratings - Over the past 90 days, 17 institutions have rated Meihao Medical, with 15 buy ratings and 2 hold ratings, indicating a generally positive outlook [4]. - The average target price set by institutions for the stock is 24.42 yuan [4].
股票行情快报：美好医疗（301363）10月16日主力资金净买入1304.85万元